SR-9011 Uses, Dosage, Side Effects and more
SR-9011 is a REV-ERB agonist. SR-9011 has been demonstrated that it is specifically lethal to cancer cells and oncogene-induced senescent cells, including melanocytic naevi, and has no effect on the viability of normal cells or tissues .
| Trade Name | SR-9011 |
| Generic | SR-9011 |
| Type | |
| Formula | C23H31ClN4O3S |
| Weight | Average: 479.04 Monoisotopic: 478.1805397 |
| Groups | Experimental |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
